Morphosys shares fall after dermatitis treatment flops

German biotech company Morphosys halted development of an experimental atopic dermatitis treatment that analysts had pinned hopes of blockbuster sales potential on, sending its shares down as much as 6.8% on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news